Cargando…

Prevalence and risk factors for efavirenz-based antiretroviral treatment–associated severe vitamin D deficiency: A prospective cohort study

Initiation of efavirenz-based combination antiretroviral therapy (cART) is associated with Vitamin D deficiency, but the risk factors including efavirenz pharmacokinetics for cART-induced severe vitamin D deficiency (SVDD) and the impact of anti-tuberculosis (TB) cotreatment are not explored. We inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nylén, Hanna, Habtewold, Abiy, Makonnen, Eyasu, Yimer, Getnet, Bertilsson, Leif, Burhenne, Jürgen, Diczfalusy, Ulf, Aklillu, Eleni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4850
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400328/ https://www.ncbi.nlm.nih.gov/pubmed/27559961 http://dx.doi.org/10.1097/MD.0000000000004631

Ejemplares similares

Early or deferred initiation of efavirenz during rifampicin‐based TB therapy has no significant effect on CYP3A induction in TB‐HIV infected patients
por: Aklillu, Eleni, et al.
Publicado: (2020)

Impact of Population and Pharmacogenetics Variations on Efavirenz Pharmacokinetics and Immunologic Outcomes During Anti-Tuberculosis Co-Therapy: A Parallel Prospective Cohort Study in Two Sub-Sahara African Populations
por: Mugusi, Sabina, et al.
Publicado: (2020)

Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients
por: Yimer, Getnet, et al.
Publicado: (2011)

HLA-B(*)57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians
por: Petros, Zelalem, et al.
Publicado: (2017)

Importance of Ethnicity, CYP2B6 and ABCB1 Genotype for Efavirenz Pharmacokinetics and Treatment Outcomes: A Parallel-Group Prospective Cohort Study in Two Sub-Saharan Africa Populations
por: Ngaimisi, Eliford, et al.
Publicado: (2013)

Constitutive androstane receptor and pregnane X receptor genotype influence efavirenz plasma concentration and CYP2B6 enzyme activity
por: Petros, Zelalem, et al.
Publicado: (2022)

Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial
por: Amogne, Wondwossen, et al.
Publicado: (2015)

Evaluation of Patterns of Liver Toxicity in Patients on Antiretroviral and Anti-Tuberculosis Drugs: A Prospective Four Arm Observational Study in Ethiopian Patients
por: Yimer, Getnet, et al.
Publicado: (2014)

No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data
por: Nkhoma, Ella T., et al.
Publicado: (2016)

Plasma Efavirenz Concentrations Are Associated With Lipid and Glucose Concentrations
por: Sinxadi, Phumla Zuleika, et al.
Publicado: (2016)

N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians
por: Aklillu, Eleni, et al.
Publicado: (2018)

Long-term efavirenz pharmacokinetics is comparable between Tanzanian HIV and HIV/Tuberculosis patients with the same CYP2B6*6 genotype
por: Kitabi, Eliford Ngaimisi, et al.
Publicado: (2018)

Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals
por: Cain, Lauren E., et al.
Publicado: (2016)

The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana
por: Maseng, Monkgomotsi J., et al.
Publicado: (2022)

Real-world efficacy and safety of dolutegravir plus lamivudine versus tenofovir plus lamivudine and efavirenz in ART-naïve HIV-1-infected adults
por: Li, Jin, et al.
Publicado: (2022)

Safety of low dose efavirenz regimen in Indian adults with HIV-1 infection: Insights from a phase 4 interventional randomised trial
por: Dravid, Ameet N., et al.
Publicado: (2023)

Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity
por: Petros, Zelalem, et al.
Publicado: (2016)

Vitamin D Status and Association of VDR Genetic Polymorphism to Risk of Breast Cancer in Ethiopia
por: Ahmed, Jemal Hussien, et al.
Publicado: (2019)

Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin
por: Mugusi, Sabina, et al.
Publicado: (2018)

Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial
por: Dravid, Ameet, et al.
Publicado: (2022)

Copy Number Variation of Fc Gamma Receptor Genes in HIV-Infected and HIV-Tuberculosis Co-Infected Individuals in Sub-Saharan Africa
por: Machado, Lee R., et al.
Publicado: (2013)

Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines
por: Treskova, Marina, et al.
Publicado: (2016)

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2016)

Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment?
por: Gutierrez-Valencia, Alicia, et al.
Publicado: (2015)

Antiretroviral treatment failure and associated factors among HIV patients on the first-line antiretroviral therapy at Mizan-Tepi University teaching hospital, Southwest Ethiopia: A cross-sectional study
por: Siraj, Jafer, et al.
Publicado: (2021)

Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals
por: Shilaih, Mohaned, et al.
Publicado: (2017)

Economic evaluation of weekends-off antiretroviral therapy for young people in 11 countries
por: Tierrablanca, Luis Enrique, et al.
Publicado: (2018)

The investigation of CD4(+)T-cell functions in primary HIV infection with antiretroviral therapy
por: Sun, Yu, et al.
Publicado: (2017)

Sarcopenia among people living with HIV and the effect of antiretroviral therapy on body composition
por: Konishi, Keiji, et al.
Publicado: (2022)

Genetic and non‐genetic factors influencing efavirenz population pharmacokinetics among human immunodeficiency virus‐1‐infected children in Ethiopia
por: Chala, Adugna, et al.
Publicado: (2023)

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach
por: Cuzin, Lise, et al.
Publicado: (2015)

Genotyping and antiretroviral drug resistance of human immunodeficiency Virus-1 in Jazan, Saudi Arabia
por: Zaki, Eitezaz A., et al.
Publicado: (2020)

Immune recovery of middle-aged HIV patients following antiretroviral therapy: An observational cohort study
por: Wong, Ngai Sze, et al.
Publicado: (2017)

Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice
por: Drozd, Daniel R., et al.
Publicado: (2017)

HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon
por: Mbouyap, Pretty Rosereine, et al.
Publicado: (2023)

Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India
por: Dravid, Ameet N., et al.
Publicado: (2018)

High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia
por: Jordan, Michael R., et al.
Publicado: (2020)

Trends & predictors of non-AIDS comorbidities among people living with HIV and receiving antiretroviral therapy in Lebanon
por: Abou Hassan, Farouk F., et al.
Publicado: (2022)

Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study
por: Masiá, Mar, et al.
Publicado: (2016)

Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy
por: Ku, Nam Su, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_06ukgoksv2at0mbbmdd9e0hhdd